Continuous Renal Replacement Therapy Market
Number of pages: 100 | Report Format: PDF | Published date: 09 February, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market size value in 2021 |
US$ 1.19 billion |
|
Revenue forecast in 2030 |
US$ 2.26 billion |
|
Growth Rate |
CAGR of 7.4% from 2022 to 2030 |
|
Base year for estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments covered |
Product, Modality, End-user, and Region. |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global continuous renal replacement therapy market was valued at US$ 1.19 billion in 2021 and is expected to witness a CAGR of 7.4%, during the forecast period from 2022 to 2030.
Market Fundamentals
Continuous renal replacement therapy (CRRT) is a favored method for controlling the hemodynamic state of patients with acute renal damage. Patients with acute renal failure and comorbidities, such as abnormalities or multiple organ failure in their circulatory systems, such as edema and heart insufficiency, are treated using continuous renal replacement therapy devices. Other risks associated with the use of these devices include postoperative liver failure, fulminant hepatitis, severe acute pancreatitis, and multiple organ failure.
[4634634]
Market Dynamics
The continuous renal replacement therapy (CRRT) market is expected to show significant growth during the forecast period. The growth of this segment is attributed to growing cases of acute kidney injury (AKI), increasing cases of sepsis, and the growing geriatric population. Additionally, technological advancement plays a crucial role in market growth due to rising research for developing advanced products with enhanced outcome. Furthermore, the market is also driven by the multidisciplinary research aspect and the large clinical benefits of this integrated technology in continuous renal replacement therapy. Moreover, the growing demand for continuous renal replacement therapy due to growth in the patient pool further fuels the growth of this market. However, the high procedure cost of CRRT and complications related to CRRT are some of the restraints in the market that can have an adverse impact on the market.
Market Ecosystem
The global continuous renal replacement therapy market has been analyzed from four perspectives: Product, Modality, End-user, and Region.
Continuous Renal Replacement Therapy Market by Product
[734633]
Based on product, the global continuous renal replacement therapy market is segmented into systems and consumables. The consumables dominate the market with the largest share owing to their short working lives, and consumables have a high and consistent demand. Consumables are further classified as hemofiltration, line sets, dialysate, and accessories. The segment growth is further driven by the high demand for consumables, large availability, economically affordable rates, and a wide range of applications. System segmented is estimated to illustrate a noticeable development during the projected timeframe. Growth in technical developments, such as continuous renal replacement therapy, high-volume permeability, and the incorporation of EMR connections, are expected to boost market expansion. Furthermore, the increasing release of advanced equipment for consistent performance in CRRT treatments stimulates the expansion of this category, consequently increasing market sales.
Continuous Renal Replacement Therapy Market by Modality
Based on modality, the global continuous renal replacement therapy market is classified into continuous venous hemofiltration, continuous venous hemodialysis, continuous venous hemodiafiltration, and slow continuous ultra-filtration. Continuous venous hemofiltration leads the market with the largest revenue share owing to the growing prevalence of fluid overload cases. Furthermore, the advantages offered by this modality, such as improved diffusion technique by reducing solutes and flexibility during the continuous renal replacement procedure, contribute to market expansion. In addition, increasing dialysis procedures further drives market development.
Continuous Renal Replacement Therapy Market by End-user
The global continuous renal replacement therapy market has been segmented based on end-users into hospitals, specialty clinics, ambulatory surgical centers, and others. Hospitals possess the majority revenue share in the market. The growth of the hospital segment can be ascribed majorly to the growing demand for continuous renal replacement therapy among the population and the large patient dynamic. Additionally, a high percentage of patient satisfaction and enhanced services support market expansion. In hospitals, continuous renal replacement therapy is most commonly used to treat acute kidney injuries (AKI). Continuous renal replacement therapy is used more frequently in critically ill patients with AKI, as it allows for continuous, slow, and gentle removal of waste products from the blood. Technology advancements have led to more compact, portable and user-friendly continuous renal replacement therapy machines, which can be used in ICU and non-ICU settings. There is a growing trend towards individualized or "patient-specific" continuous renal replacement therapy, where treatment parameters are tailored to each patient's specific needs. Continuous renal replacement therapy is being used in combination with other therapies, such as hemodialysis and peritoneal dialysis, to provide optimal treatment for patients with AKI. Overall, continuous renal replacement therapy is an important and evolving therapy for treating AKI in hospital settings. Such trends are helping to improve patient outcomes and quality of care further.
Continuous Renal Replacement Therapy Market by Region
Geographically, the global continuous renal replacement therapy market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the market. The growth of this region can be attributed to the massive base of the aged population and the rise in cases of chronic kidney diseases. High demand for CRRT due to the continued approval of novel products by the penetration of advanced technologies and interfaces encourages the growth of this region’s market. Additionally, the presence of major market players and the high awareness of CVVT among the population further fuel the growth of this regional market. Europe holds the second largest share in the market due to the rapid adoption of technologically advanced products and the presence of a well-developed healthcare system.
Asia Pacific is the fastest-emerging economy in the global continuous renal replacement therapy market, ascribed to developing healthcare infrastructure and advancing healthcare facilities. Moreover, the rising sepsis and kidney failure incidence are responsible for this regional market growth. Additionally, growing government initiatives and awareness campaigns boost this regional market development.
Furthermore, the demand for continuous renal replacement therapy is perpetually increasing in the Middle East & Africa markets. The prevalence of chronic kidney disease and acute kidney injury is on the rise in the Middle East & Africa region, driving demand for continuous renal replacement therapy. The development of healthcare infrastructure, including the expansion of dialysis centers and the availability of specialized healthcare providers, has led to increased access to continuous renal replacement therapy in the region. Government and non-government organizations have launched awareness campaigns to educate the public about kidney disease screening and treatment's importance, which has helped increase demand for continuous renal replacement therapy. The growth of the middle class in the MEA region has led to increased spending on health and wellness, including the demand for advanced renal replacement therapies like continuous renal replacement therapy. The overall economic growth of the MEA region has led to increased investment in healthcare infrastructure and the availability of cutting-edge medical technologies, including continuous renal replacement therapy. In conclusion, the demand for continuous renal replacement therapy is growing in the MEA region, driven by a combination of increasing incidence of kidney disease, growing healthcare infrastructure, increased public awareness, and economic growth.
Competitive Landscape
The prominent players operating in the global continuous renal replacement therapy market are:
The global continuous renal replacement therapy market was US$ 1.19 billion in 2021.
The estimated market size of the global continuous renal replacement therapy market in 2030 is US$ 2.26 billion.
The growing prevalence of continuous renal replacement therapy, rising novel product approvals, and increasing demand for continuous renal replacement therapy are a few growth drivers of the global continuous renal replacement therapy market.
The global continuous renal replacement therapy market is expected to grow at a CAGR of 7.4% from 2022 to 2030.
The high cost of advanced treatments and the high complexity of continuous renal replacement therapy procedures can be some of the major hurdles to the optimal growth of this market.
*Insights on financial performance are subject to the availability of information in the public domain
Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.
GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.
Snehal Deshmukh
Principle Consultant
Speak to analyst